Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Dexmedetomidine Supplemented Analgesia on Delirium and Long-term Outcomes in Elderly After Hip Fracture Surgery: A Multicenter, Double-blinded, Randomized Controlled Trial

NCT04955249 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT04955249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04955249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Dexmedetomidine Supplemented Analgesia on Delirium and Long-term Outcomes in Elderly After Hip Fracture Surgery: A Multicenter, Double-blinded, Randomized Controlled Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Terminated
Start date
November 18, 2021
Completion date
May 11, 2023
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, elderly, hip fracture surgery, patient-controlled analgesia, postoperative delirium